Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Contact Levi & Korsinsky About Fraud Investigation
New York, New York--(Newsfile Corp. - March 3, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into PROCEPT BioRobotics Corporation ("PROCEPT BioRobotics Corporation") (NASDAQ: PRCT) concerning potential violations of the federal securities laws.On the Q3 2025 earnings call on November 4, 2025, CFO Kevin Waters reaffirmed the $325.5 million revenue target and stated the company was "maintaining handpiece average selling prices to be approximately $3,200." CEO Larry Wood a ...